Jalpa A. Doshi
Leon Hess Professor in Internal Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Fellow, Institute on Aging, University of Pennsylvania
Director, Value Based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania
Director, Economic Evaluations Unit, Center for Evidence-Based Practice, University of Pennsylvania Health System
Associate Director , ECRI-Penn Medicine Evidence-based Practice Center (EPC) funded by the Agency for Healthcare Research and Quality
Senior Fellow, Center for Public Health Initiatives, University of Pennsylvania
Department: Medicine
Contact information
1223 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
423 Guardian Drive
Philadelphia, PA 19104
Office: (215) 898-7989
Education:
BPharm (Pharmaceutical Sciences)
Bombay College of Pharmacy, University of Bombay (Mumbai), India, 1999.
MS (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2001.
PhD (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2003.
Permanent linkBPharm (Pharmaceutical Sciences)
Bombay College of Pharmacy, University of Bombay (Mumbai), India, 1999.
MS (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2001.
PhD (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2003.
Selected Publications
Klebanoff MJ, Li P, Long JA, Doshi JA: "Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists" JAMA(In Press), 2025Li P, Geng Z, Benson C, Patel C, Doshi JA: "Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia" Advances in Therapy 42(2): 1251-1264, 2025.
Doshi JA, Li P, Klebanoff MJ, Lin JK : "Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs" JAMA Health Forum 6(5): e251387-e251387, 2025.
Huntington SF, Rhodes JM, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Marx SE, Doshi JA : "Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia" JCO Oncology Practice 21(8): 1124-1133, 2025.
Doshi JA, Li P, Asthana S, Lin JK: "Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan" JCO Oncology Practice Page: OP-24-00937, 2025.
Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA: "Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis" Neurology Clinical Practice 15(6), 2025.
Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA: "Racial and ethnic disparities along the treatment cascade among Medicare fee-for-service beneficiaries with metastatic breast, colorectal, lung, and prostate cancers" Journal of Clinical Oncology 2025.
Thirukumaran CP, Schloemann DT, Doshi JA, Fiscella KA, Ricciardi BF, Rosenthal MB: "Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults" JAMA Network Open 8(4): e254448-e254448, 2025.
Paruzzo L, Eshaghi K, Ghilardi G, Doucette A, Ho M, Carturan A, Vogl DT, Waxman AJ, Kapur S, Fardella E, Pucillo M, Imparato A, Stella F, Guruprasad P, De Souza VB, Maillie L, Kaparis S, Bouvier S, Cohen AD, Doshi JA, Porter DL, Garfall AL, Stadtmauer EA, Guerra CE, Adaniya SP, Ruella M: "Access and outcomes of racial and ethnic minority populations receiving commercial anti-BCMA CART for myeloma" Blood Immunology & Cellular Therapy Page: 100007, 2025.
Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA: "Real‐World Analysis of Adverse Event Rates after Initiation of Ibrutinib among Medicare Beneficiaries with Chronic Lymphocytic Leukemia" Cancer Medicine 13(2): e6953, 2024.